Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Genetron Holdings Ltd ADR (GTH)

Genetron Holdings Ltd ADR (GTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Wall Street - NYSE Full View
Stocks Climb Before the Open as Bond Yields Fall, U.S. Inflation Data Looms Barchart - Thu Oct 12, 2023

December S&P 500 futures (ESZ23) are up +0.43%, and December Nasdaq 100 E-Mini futures (NQZ23) are up +0.46% this morning as U.S. Treasury yields continued to fall, while market participants braced for...

ESZ23 : 4,694.27s (-0.58%)
NQZ23 : 16,530.23s (-0.07%)
GOOGL : 164.76 (-1.71%)
META : 559.14 (-0.70%)
AMGN : 294.53 (+1.60%)
XOM : 121.79 (-0.11%)
DVA : 165.51 (+0.83%)
BAX : 33.21 (+0.67%)
FAST : 83.08 (+0.87%)
DAL : 63.34 (unch)
WBA : 8.66 (+4.34%)
DPZ : 453.35 (+1.68%)
Genetron Health to Participate in the Goldman Sachs Healthcare Corporate Day Globe Newswire - Thu Jun 16, 2022

BEIJING, June 16, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology...

GTH : 4.03 (+0.12%)
Genetron Health Receives CAP Accreditation for its Maryland Laboratory Globe Newswire - Wed Jun 15, 2022

BEIJING, June 15, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology...

GTH : 4.03 (+0.12%)
Genetron Health Reports Unaudited First Quarter 2022 Financial Results Globe Newswire - Thu Jun 2, 2022

BEIJING, June 02, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology...

GTH : 4.03 (+0.12%)
Genetron Health Releases 10 New Research Results at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting Globe Newswire - Thu Jun 2, 2022

BEIJING, June 02, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology...

GTH : 4.03 (+0.12%)
Genetron Health Receives CE Mark for FusionScan Plus Kit for Human Multi-Genes Globe Newswire - Wed Jun 1, 2022

BEIJING, June 01, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology...

GTH : 4.03 (+0.12%)
Genetron Health to Announce First Quarter 2022 Unaudited Financial Results and Host Investor Call on June 2, 2022 Globe Newswire - Mon May 23, 2022

BEIJING, May 23, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology...

GTH : 4.03 (+0.12%)
Genetron Health Receives CE Mark for Human B Lymphocyte Minimal Residual Disease Detection Kit Seq-MRD® Globe Newswire - Tue Apr 19, 2022

BEIJING, April 19, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology...

GTH : 4.03 (+0.12%)
Genetron Health Presents 17 New Research Results at American Association for Cancer Research Annual Meeting (AACR) 2022 Globe Newswire - Fri Apr 8, 2022

BEIJING, April 08, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology...

GTH : 4.03 (+0.12%)
Publication in Clinical and Translational Medicine Demonstrates Mutation Capsule™’s potential in MRD Assay Developments Globe Newswire - Thu Apr 7, 2022

BEIJING, April 07, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology...

GTH : 4.03 (+0.12%)

Barchart Exclusives

3 High-Yielding Dividend Kings to Boost Your Income in 2025 and Beyond Barchart - Fri Nov 22, 6:00PM CST
These three high-quality companies are currently on sale, offering elevated yields that appeal to dividend growth investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot